Warren D. Shlomchik

Warren D. Shlomchik

Oncology
5115 Centre Avenue, Floor 4
Pittsburgh, PA 15232

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

A platform for parallel TCR cloning and testing enables anti-neoantigen tumor immunotherapy.

A platform for parallel TCR cloning and testing enables anti-neoantigen tumor immunotherapy.

Journal: JCI insight
Published: April 28, 2026

A platform for parallel T cell receptor cloning and testing enables anti-neoantigen tumor immunotherapy.

A platform for parallel T cell receptor cloning and testing enables anti-neoantigen tumor immunotherapy.

Journal: JCI insight
Published: April 28, 2026

Rapid Metagenomic Sequencing of Bronchoalveolar Lavage Fluid for Diagnosis of Infection in Patients With Hematologic Malignancies and Pulmonary Complications.

Rapid Metagenomic Sequencing of Bronchoalveolar Lavage Fluid for Diagnosis of Infection in Patients With Hematologic Malignancies and Pulmonary Complications.

Journal: CHEST pulmonary
Published: February 09, 2026

High-throughput cloning reveals diverse properties of T-cell receptors targeting minor histocompatibility antigens.

High-throughput cloning reveals diverse properties of T-cell receptors targeting minor histocompatibility antigens.

Journal: Blood advances
Published: July 09, 2025

High-throughput cloning reveals diverse properties of T-cell receptors targeting minor histocompatibility antigens.

High-throughput cloning reveals diverse properties of T-cell receptors targeting minor histocompatibility antigens.

Journal: Blood advances
Published: July 09, 2025

Comparative Analysis of Lymphodepletion Regimens in CART-19 Treatment for Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Comparative Analysis of Lymphodepletion Regimens in CART-19 Treatment for Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Journal: Transplantation and cellular therapy
Published: July 02, 2025

IFN-γ and donor leukocyte infusions for relapsed myeloblastic malignancies after allogeneic hematopoietic stem cell transplantation.

IFN-γ and donor leukocyte infusions for relapsed myeloblastic malignancies after allogeneic hematopoietic stem cell transplantation.

Journal: JCI insight
Published: January 07, 2025

Maintenance strategies for relapse prevention and treatment.

Maintenance strategies for relapse prevention and treatment.

Journal: Hematology. American Society of Hematology. Education Program
Published: December 07, 2024

The role of TCF-1+CD8+ exhausted progenitors and TCF-1 in graft-versus-host responses.

The role of TCF-1+CD8+ exhausted progenitors and TCF-1 in graft-versus-host responses.

Journal: JCI insight
Published: April 01, 2024

Chemokine receptors are required for effector T-cell trafficking to GVHD tissues but not to bone marrow.

Chemokine receptors are required for effector T-cell trafficking to GVHD tissues but not to bone marrow.

Journal: Blood advances
Published: March 28, 2024

Natalizumab for GVHD: too little or too late?

Natalizumab for GVHD: too little or too late?

Journal: Blood advances
Published: September 12, 2023

Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15.

Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15.

Journal: Science immunology
Published: April 21, 2023
Showing 1-12 of 36

Last Updated: 09/26/2026